APDN Applied DNA Sciences
- 0.145
- -0.007-4.86%
Applied DNA Sciences News
S-1: General form for registration of securities under the Securities Act of 1933
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Current report
8-K: Current report
8-K: Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
8-K: Poll Results of 2024 Stockholders Meeting
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Applied DNA Sciences | 8-K: Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
DEFA14A: Others
DEF 14A: Definitive information statements
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Announcement of Resolutions of Extraordinary General Meeting of Shareholders
8-K: Current report
8-K: Applied DNA Sciences Re-Complies with NASDAQ Listing Rule 5550(b)(1) Notice
DEFA14A: Others
DEF 14A: Definitive information statements
8-K: Applied DNA Sciences Does Not Comply with NASDAQ Listing Rule 5550(b)(1) Notice
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Applied DNA Announces Pricing of $12 Million Public Offering
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Analysis
Price Target
No Data
No Data
